VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171,000 | -45.0% | 18,257 | +44.0% | 0.00% | – |
| Q2 2023 | $311,000 | +49.5% | 12,678 | +41.4% | 0.00% | – |
| Q1 2023 | $208,000 | -42.2% | 8,965 | -36.9% | 0.00% | – |
| Q4 2022 | $360,000 | +355.7% | 14,198 | +244.2% | 0.00% | – |
| Q3 2022 | $79,000 | -14.1% | 4,125 | +14.1% | 0.00% | – |
| Q2 2022 | $92,000 | -73.0% | 3,615 | -72.7% | 0.00% | – |
| Q1 2022 | $341,000 | -41.7% | 13,253 | -5.2% | 0.00% | – |
| Q4 2021 | $585,000 | +5218.2% | 13,978 | +5491.2% | 0.00% | – |
| Q3 2021 | $11,000 | -8.3% | 250 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -90.1% | 250 | -89.4% | 0.00% | – |
| Q1 2021 | $121,000 | +2925.0% | 2,368 | +1427.7% | 0.00% | – |
| Q4 2020 | $4,000 | -33.3% | 155 | -11.9% | 0.00% | – |
| Q3 2020 | $6,000 | -40.0% | 176 | -29.6% | 0.00% | – |
| Q2 2020 | $10,000 | +42.9% | 250 | +15.7% | 0.00% | – |
| Q1 2020 | $7,000 | +16.7% | 216 | -57.1% | 0.00% | – |
| Q4 2019 | $6,000 | – | 503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |